Post-earnings recap
Reported
Mon, Nov 4, 2024
EPS actual
$-0.60
EPS est.
$-0.67
EPS surprise
+9.91%
1-day move
+4.90%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
IDEAYA Biosciences I's earnings report shows a smaller-than-expected loss per share, which pleased investors and led to a 4.9% increase in stock price. The company did not provide revenue figures or future guidance, but management's positive tone suggests confidence in their ongoing projects. Investors may view the EPS beat as a sign of improving operational efficiency.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.60 | N/A | +9.91% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the quarter's performance, highlighting progress in their pipeline. They emphasized a commitment to stakeholder value.
We are pleased with our progress this quarter.
Our focus remains on advancing our pipeline.
We are committed to delivering value to our stakeholders.